Page last updated: 2024-11-07

dextroamphetamine and Ischemic Attack, Transient

dextroamphetamine has been researched along with Ischemic Attack, Transient in 1 studies

Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.

Ischemic Attack, Transient: Brief reversible episodes of focal, nonconvulsive ischemic dysfunction of the brain having a duration of less than 24 hours, and usually less than one hour, caused by transient thrombotic or embolic blood vessel occlusion or stenosis. Events may be classified by arterial distribution, temporal pattern, or etiology (e.g., embolic vs. thrombotic). (From Adams et al., Principles of Neurology, 6th ed, pp814-6)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Borlongan, CV1
Martinez, R1
Shytle, RD1
Freeman, TB1
Cahill, DW1
Sanberg, PR1

Other Studies

1 other study available for dextroamphetamine and Ischemic Attack, Transient

ArticleYear
Striatal dopamine-mediated motor behavior is altered following occlusion of the middle cerebral artery.
    Pharmacology, biochemistry, and behavior, 1995, Volume: 52, Issue:1

    Topics: Animals; Catalepsy; Cerebral Arteries; Dextroamphetamine; Dopamine; Dopamine Agents; Dopamine Antago

1995